Global DNA & RNA Oligonucleotides Market 2023 by Company, Regions, Type and Application, Forecast to 2029

Page: 100

Published Date: 09 Jan 2023

Category: Pharma & Healthcare

PDF Download

Get FREE Sample

Customize Request

Description
Table of Contents
Table of Figures
Research Methodology
Companies Mentioned
Related Reports
Product Tags

Description

According to our (Global Info Research) latest study, the global DNA & RNA Oligonucleotides market size was valued at USD million in 2022 and is forecast to a readjusted size of USD million by 2029 with a CAGR of % during review period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.

This report is a detailed and comprehensive analysis for global DNA & RNA Oligonucleotides market. Both quantitative and qualitative analyses are presented by company, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2023, are provided.

Key Features:
Global DNA & RNA Oligonucleotides market size and forecasts, in consumption value ($ Million), 2018-2029
Global DNA & RNA Oligonucleotides market size and forecasts by region and country, in consumption value ($ Million), 2018-2029
Global DNA & RNA Oligonucleotides market size and forecasts, by Type and by Application, in consumption value ($ Million), 2018-2029
Global DNA & RNA Oligonucleotides market shares of main players, in revenue ($ Million), 2018-2023
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for DNA & RNA Oligonucleotides
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global DNA & RNA Oligonucleotides market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Eurofins Scientific, Natera, BGI, Illumina and Roche, etc.

This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.

Market segmentation
DNA & RNA Oligonucleotides market is split by Type and by Application. For the period 2018-2029, the growth among segments provide accurate calculations and forecasts for consumption value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.

Market segment by Type
    DNA Oligonucleotides
    RNA Oligonucleotides

Market segment by Application
    Hospitals and Clinics
    Biopharma Companies
    Academic & Research Organizations
    Others

Market segment by players, this report covers
    Eurofins Scientific
    Natera
    BGI
    Illumina
    Roche
    LabCorp
    Berry Genomics
    Brooks Life Sciences
    Macrogen
    Genotypic Technology
    Dna Link

Market segment by regions, regional analysis covers
    North America (United States, Canada, and Mexico)
    Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
    Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia and Rest of Asia-Pacific)
    South America (Brazil, Argentina and Rest of South America)
    Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)

The content of the study subjects, includes a total of 13 chapters:
Chapter 1, to describe DNA & RNA Oligonucleotides product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of DNA & RNA Oligonucleotides, with revenue, gross margin and global market share of DNA & RNA Oligonucleotides from 2018 to 2023.
Chapter 3, the DNA & RNA Oligonucleotides competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and application, with consumption value and growth rate by Type, application, from 2018 to 2029.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2018 to 2023.and DNA & RNA Oligonucleotides market forecast, by regions, type and application, with consumption value, from 2024 to 2029.
Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis, and Influence of COVID-19 and Russia-Ukraine War
Chapter 12, the key raw materials and key suppliers, and industry chain of DNA & RNA Oligonucleotides.
Chapter 13, to describe DNA & RNA Oligonucleotides research findings and conclusion.

Table of Contents

1 Market Overview
    1.1 Product Overview and Scope of DNA & RNA Oligonucleotides
    1.2 Market Estimation Caveats and Base Year
    1.3 Classification of DNA & RNA Oligonucleotides by Type
        1.3.1 Overview: Global DNA & RNA Oligonucleotides Market Size by Type: 2018 Versus 2022 Versus 2029
        1.3.2 Global DNA & RNA Oligonucleotides Consumption Value Market Share by Type in 2022
        1.3.3 DNA Oligonucleotides
        1.3.4 RNA Oligonucleotides
    1.4 Global DNA & RNA Oligonucleotides Market by Application
        1.4.1 Overview: Global DNA & RNA Oligonucleotides Market Size by Application: 2018 Versus 2022 Versus 2029
        1.4.2 Hospitals and Clinics
        1.4.3 Biopharma Companies
        1.4.4 Academic & Research Organizations
        1.4.5 Others
    1.5 Global DNA & RNA Oligonucleotides Market Size & Forecast
    1.6 Global DNA & RNA Oligonucleotides Market Size and Forecast by Region
        1.6.1 Global DNA & RNA Oligonucleotides Market Size by Region: 2018 VS 2022 VS 2029
        1.6.2 Global DNA & RNA Oligonucleotides Market Size by Region, (2018-2029)
        1.6.3 North America DNA & RNA Oligonucleotides Market Size and Prospect (2018-2029)
        1.6.4 Europe DNA & RNA Oligonucleotides Market Size and Prospect (2018-2029)
        1.6.5 Asia-Pacific DNA & RNA Oligonucleotides Market Size and Prospect (2018-2029)
        1.6.6 South America DNA & RNA Oligonucleotides Market Size and Prospect (2018-2029)
        1.6.7 Middle East and Africa DNA & RNA Oligonucleotides Market Size and Prospect (2018-2029)

2 Company Profiles
    2.1 Eurofins Scientific
        2.1.1 Eurofins Scientific Details
        2.1.2 Eurofins Scientific Major Business
        2.1.3 Eurofins Scientific DNA & RNA Oligonucleotides Product and Solutions
        2.1.4 Eurofins Scientific DNA & RNA Oligonucleotides Revenue, Gross Margin and Market Share (2018-2023)
        2.1.5 Eurofins Scientific Recent Developments and Future Plans
    2.2 Natera
        2.2.1 Natera Details
        2.2.2 Natera Major Business
        2.2.3 Natera DNA & RNA Oligonucleotides Product and Solutions
        2.2.4 Natera DNA & RNA Oligonucleotides Revenue, Gross Margin and Market Share (2018-2023)
        2.2.5 Natera Recent Developments and Future Plans
    2.3 BGI
        2.3.1 BGI Details
        2.3.2 BGI Major Business
        2.3.3 BGI DNA & RNA Oligonucleotides Product and Solutions
        2.3.4 BGI DNA & RNA Oligonucleotides Revenue, Gross Margin and Market Share (2018-2023)
        2.3.5 BGI Recent Developments and Future Plans
    2.4 Illumina
        2.4.1 Illumina Details
        2.4.2 Illumina Major Business
        2.4.3 Illumina DNA & RNA Oligonucleotides Product and Solutions
        2.4.4 Illumina DNA & RNA Oligonucleotides Revenue, Gross Margin and Market Share (2018-2023)
        2.4.5 Illumina Recent Developments and Future Plans
    2.5 Roche
        2.5.1 Roche Details
        2.5.2 Roche Major Business
        2.5.3 Roche DNA & RNA Oligonucleotides Product and Solutions
        2.5.4 Roche DNA & RNA Oligonucleotides Revenue, Gross Margin and Market Share (2018-2023)
        2.5.5 Roche Recent Developments and Future Plans
    2.6 LabCorp
        2.6.1 LabCorp Details
        2.6.2 LabCorp Major Business
        2.6.3 LabCorp DNA & RNA Oligonucleotides Product and Solutions
        2.6.4 LabCorp DNA & RNA Oligonucleotides Revenue, Gross Margin and Market Share (2018-2023)
        2.6.5 LabCorp Recent Developments and Future Plans
    2.7 Berry Genomics
        2.7.1 Berry Genomics Details
        2.7.2 Berry Genomics Major Business
        2.7.3 Berry Genomics DNA & RNA Oligonucleotides Product and Solutions
        2.7.4 Berry Genomics DNA & RNA Oligonucleotides Revenue, Gross Margin and Market Share (2018-2023)
        2.7.5 Berry Genomics Recent Developments and Future Plans
    2.8 Brooks Life Sciences
        2.8.1 Brooks Life Sciences Details
        2.8.2 Brooks Life Sciences Major Business
        2.8.3 Brooks Life Sciences DNA & RNA Oligonucleotides Product and Solutions
        2.8.4 Brooks Life Sciences DNA & RNA Oligonucleotides Revenue, Gross Margin and Market Share (2018-2023)
        2.8.5 Brooks Life Sciences Recent Developments and Future Plans
    2.9 Macrogen
        2.9.1 Macrogen Details
        2.9.2 Macrogen Major Business
        2.9.3 Macrogen DNA & RNA Oligonucleotides Product and Solutions
        2.9.4 Macrogen DNA & RNA Oligonucleotides Revenue, Gross Margin and Market Share (2018-2023)
        2.9.5 Macrogen Recent Developments and Future Plans
    2.10 Genotypic Technology
        2.10.1 Genotypic Technology Details
        2.10.2 Genotypic Technology Major Business
        2.10.3 Genotypic Technology DNA & RNA Oligonucleotides Product and Solutions
        2.10.4 Genotypic Technology DNA & RNA Oligonucleotides Revenue, Gross Margin and Market Share (2018-2023)
        2.10.5 Genotypic Technology Recent Developments and Future Plans
    2.11 Dna Link
        2.11.1 Dna Link Details
        2.11.2 Dna Link Major Business
        2.11.3 Dna Link DNA & RNA Oligonucleotides Product and Solutions
        2.11.4 Dna Link DNA & RNA Oligonucleotides Revenue, Gross Margin and Market Share (2018-2023)
        2.11.5 Dna Link Recent Developments and Future Plans

3 Market Competition, by Players
    3.1 Global DNA & RNA Oligonucleotides Revenue and Share by Players (2018-2023)
    3.2 Market Share Analysis (2022)
        3.2.1 Market Share of DNA & RNA Oligonucleotides by Company Revenue
        3.2.2 Top 3 DNA & RNA Oligonucleotides Players Market Share in 2022
        3.2.3 Top 6 DNA & RNA Oligonucleotides Players Market Share in 2022
    3.3 DNA & RNA Oligonucleotides Market: Overall Company Footprint Analysis
        3.3.1 DNA & RNA Oligonucleotides Market: Region Footprint
        3.3.2 DNA & RNA Oligonucleotides Market: Company Product Type Footprint
        3.3.3 DNA & RNA Oligonucleotides Market: Company Product Application Footprint
    3.4 New Market Entrants and Barriers to Market Entry
    3.5 Mergers, Acquisition, Agreements, and Collaborations

4 Market Size Segment by Type
    4.1 Global DNA & RNA Oligonucleotides Consumption Value and Market Share by Type (2018-2023)
    4.2 Global DNA & RNA Oligonucleotides Market Forecast by Type (2024-2029)

5 Market Size Segment by Application
    5.1 Global DNA & RNA Oligonucleotides Consumption Value Market Share by Application (2018-2023)
    5.2 Global DNA & RNA Oligonucleotides Market Forecast by Application (2024-2029)

6 North America
    6.1 North America DNA & RNA Oligonucleotides Consumption Value by Type (2018-2029)
    6.2 North America DNA & RNA Oligonucleotides Consumption Value by Application (2018-2029)
    6.3 North America DNA & RNA Oligonucleotides Market Size by Country
        6.3.1 North America DNA & RNA Oligonucleotides Consumption Value by Country (2018-2029)
        6.3.2 United States DNA & RNA Oligonucleotides Market Size and Forecast (2018-2029)
        6.3.3 Canada DNA & RNA Oligonucleotides Market Size and Forecast (2018-2029)
        6.3.4 Mexico DNA & RNA Oligonucleotides Market Size and Forecast (2018-2029)

7 Europe
    7.1 Europe DNA & RNA Oligonucleotides Consumption Value by Type (2018-2029)
    7.2 Europe DNA & RNA Oligonucleotides Consumption Value by Application (2018-2029)
    7.3 Europe DNA & RNA Oligonucleotides Market Size by Country
        7.3.1 Europe DNA & RNA Oligonucleotides Consumption Value by Country (2018-2029)
        7.3.2 Germany DNA & RNA Oligonucleotides Market Size and Forecast (2018-2029)
        7.3.3 France DNA & RNA Oligonucleotides Market Size and Forecast (2018-2029)
        7.3.4 United Kingdom DNA & RNA Oligonucleotides Market Size and Forecast (2018-2029)
        7.3.5 Russia DNA & RNA Oligonucleotides Market Size and Forecast (2018-2029)
        7.3.6 Italy DNA & RNA Oligonucleotides Market Size and Forecast (2018-2029)

8 Asia-Pacific
    8.1 Asia-Pacific DNA & RNA Oligonucleotides Consumption Value by Type (2018-2029)
    8.2 Asia-Pacific DNA & RNA Oligonucleotides Consumption Value by Application (2018-2029)
    8.3 Asia-Pacific DNA & RNA Oligonucleotides Market Size by Region
        8.3.1 Asia-Pacific DNA & RNA Oligonucleotides Consumption Value by Region (2018-2029)
        8.3.2 China DNA & RNA Oligonucleotides Market Size and Forecast (2018-2029)
        8.3.3 Japan DNA & RNA Oligonucleotides Market Size and Forecast (2018-2029)
        8.3.4 South Korea DNA & RNA Oligonucleotides Market Size and Forecast (2018-2029)
        8.3.5 India DNA & RNA Oligonucleotides Market Size and Forecast (2018-2029)
        8.3.6 Southeast Asia DNA & RNA Oligonucleotides Market Size and Forecast (2018-2029)
        8.3.7 Australia DNA & RNA Oligonucleotides Market Size and Forecast (2018-2029)

9 South America
    9.1 South America DNA & RNA Oligonucleotides Consumption Value by Type (2018-2029)
    9.2 South America DNA & RNA Oligonucleotides Consumption Value by Application (2018-2029)
    9.3 South America DNA & RNA Oligonucleotides Market Size by Country
        9.3.1 South America DNA & RNA Oligonucleotides Consumption Value by Country (2018-2029)
        9.3.2 Brazil DNA & RNA Oligonucleotides Market Size and Forecast (2018-2029)
        9.3.3 Argentina DNA & RNA Oligonucleotides Market Size and Forecast (2018-2029)

10 Middle East & Africa
    10.1 Middle East & Africa DNA & RNA Oligonucleotides Consumption Value by Type (2018-2029)
    10.2 Middle East & Africa DNA & RNA Oligonucleotides Consumption Value by Application (2018-2029)
    10.3 Middle East & Africa DNA & RNA Oligonucleotides Market Size by Country
        10.3.1 Middle East & Africa DNA & RNA Oligonucleotides Consumption Value by Country (2018-2029)
        10.3.2 Turkey DNA & RNA Oligonucleotides Market Size and Forecast (2018-2029)
        10.3.3 Saudi Arabia DNA & RNA Oligonucleotides Market Size and Forecast (2018-2029)
        10.3.4 UAE DNA & RNA Oligonucleotides Market Size and Forecast (2018-2029)

11 Market Dynamics
    11.1 DNA & RNA Oligonucleotides Market Drivers
    11.2 DNA & RNA Oligonucleotides Market Restraints
    11.3 DNA & RNA Oligonucleotides Trends Analysis
    11.4 Porters Five Forces Analysis
        11.4.1 Threat of New Entrants
        11.4.2 Bargaining Power of Suppliers
        11.4.3 Bargaining Power of Buyers
        11.4.4 Threat of Substitutes
        11.4.5 Competitive Rivalry
    11.5 Influence of COVID-19 and Russia-Ukraine War
        11.5.1 Influence of COVID-19
        11.5.2 Influence of Russia-Ukraine War

12 Industry Chain Analysis
    12.1 DNA & RNA Oligonucleotides Industry Chain
    12.2 DNA & RNA Oligonucleotides Upstream Analysis
    12.3 DNA & RNA Oligonucleotides Midstream Analysis
    12.4 DNA & RNA Oligonucleotides Downstream Analysis

13 Research Findings and Conclusion

14 Appendix
    14.1 Methodology
    14.2 Research Process and Data Source
    14.3 Disclaimer

Table of Figures

List of Tables
    Table 1. Global DNA & RNA Oligonucleotides Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
    Table 2. Global DNA & RNA Oligonucleotides Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
    Table 3. Global DNA & RNA Oligonucleotides Consumption Value by Region (2018-2023) & (USD Million)
    Table 4. Global DNA & RNA Oligonucleotides Consumption Value by Region (2024-2029) & (USD Million)
    Table 5. Eurofins Scientific Company Information, Head Office, and Major Competitors
    Table 6. Eurofins Scientific Major Business
    Table 7. Eurofins Scientific DNA & RNA Oligonucleotides Product and Solutions
    Table 8. Eurofins Scientific DNA & RNA Oligonucleotides Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 9. Eurofins Scientific Recent Developments and Future Plans
    Table 10. Natera Company Information, Head Office, and Major Competitors
    Table 11. Natera Major Business
    Table 12. Natera DNA & RNA Oligonucleotides Product and Solutions
    Table 13. Natera DNA & RNA Oligonucleotides Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 14. Natera Recent Developments and Future Plans
    Table 15. BGI Company Information, Head Office, and Major Competitors
    Table 16. BGI Major Business
    Table 17. BGI DNA & RNA Oligonucleotides Product and Solutions
    Table 18. BGI DNA & RNA Oligonucleotides Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 19. BGI Recent Developments and Future Plans
    Table 20. Illumina Company Information, Head Office, and Major Competitors
    Table 21. Illumina Major Business
    Table 22. Illumina DNA & RNA Oligonucleotides Product and Solutions
    Table 23. Illumina DNA & RNA Oligonucleotides Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 24. Illumina Recent Developments and Future Plans
    Table 25. Roche Company Information, Head Office, and Major Competitors
    Table 26. Roche Major Business
    Table 27. Roche DNA & RNA Oligonucleotides Product and Solutions
    Table 28. Roche DNA & RNA Oligonucleotides Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 29. Roche Recent Developments and Future Plans
    Table 30. LabCorp Company Information, Head Office, and Major Competitors
    Table 31. LabCorp Major Business
    Table 32. LabCorp DNA & RNA Oligonucleotides Product and Solutions
    Table 33. LabCorp DNA & RNA Oligonucleotides Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 34. LabCorp Recent Developments and Future Plans
    Table 35. Berry Genomics Company Information, Head Office, and Major Competitors
    Table 36. Berry Genomics Major Business
    Table 37. Berry Genomics DNA & RNA Oligonucleotides Product and Solutions
    Table 38. Berry Genomics DNA & RNA Oligonucleotides Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 39. Berry Genomics Recent Developments and Future Plans
    Table 40. Brooks Life Sciences Company Information, Head Office, and Major Competitors
    Table 41. Brooks Life Sciences Major Business
    Table 42. Brooks Life Sciences DNA & RNA Oligonucleotides Product and Solutions
    Table 43. Brooks Life Sciences DNA & RNA Oligonucleotides Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 44. Brooks Life Sciences Recent Developments and Future Plans
    Table 45. Macrogen Company Information, Head Office, and Major Competitors
    Table 46. Macrogen Major Business
    Table 47. Macrogen DNA & RNA Oligonucleotides Product and Solutions
    Table 48. Macrogen DNA & RNA Oligonucleotides Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 49. Macrogen Recent Developments and Future Plans
    Table 50. Genotypic Technology Company Information, Head Office, and Major Competitors
    Table 51. Genotypic Technology Major Business
    Table 52. Genotypic Technology DNA & RNA Oligonucleotides Product and Solutions
    Table 53. Genotypic Technology DNA & RNA Oligonucleotides Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 54. Genotypic Technology Recent Developments and Future Plans
    Table 55. Dna Link Company Information, Head Office, and Major Competitors
    Table 56. Dna Link Major Business
    Table 57. Dna Link DNA & RNA Oligonucleotides Product and Solutions
    Table 58. Dna Link DNA & RNA Oligonucleotides Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 59. Dna Link Recent Developments and Future Plans
    Table 60. Global DNA & RNA Oligonucleotides Revenue (USD Million) by Players (2018-2023)
    Table 61. Global DNA & RNA Oligonucleotides Revenue Share by Players (2018-2023)
    Table 62. Breakdown of DNA & RNA Oligonucleotides by Company Type (Tier 1, Tier 2, and Tier 3)
    Table 63. Market Position of Players in DNA & RNA Oligonucleotides, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2022
    Table 64. Head Office of Key DNA & RNA Oligonucleotides Players
    Table 65. DNA & RNA Oligonucleotides Market: Company Product Type Footprint
    Table 66. DNA & RNA Oligonucleotides Market: Company Product Application Footprint
    Table 67. DNA & RNA Oligonucleotides New Market Entrants and Barriers to Market Entry
    Table 68. DNA & RNA Oligonucleotides Mergers, Acquisition, Agreements, and Collaborations
    Table 69. Global DNA & RNA Oligonucleotides Consumption Value (USD Million) by Type (2018-2023)
    Table 70. Global DNA & RNA Oligonucleotides Consumption Value Share by Type (2018-2023)
    Table 71. Global DNA & RNA Oligonucleotides Consumption Value Forecast by Type (2024-2029)
    Table 72. Global DNA & RNA Oligonucleotides Consumption Value by Application (2018-2023)
    Table 73. Global DNA & RNA Oligonucleotides Consumption Value Forecast by Application (2024-2029)
    Table 74. North America DNA & RNA Oligonucleotides Consumption Value by Type (2018-2023) & (USD Million)
    Table 75. North America DNA & RNA Oligonucleotides Consumption Value by Type (2024-2029) & (USD Million)
    Table 76. North America DNA & RNA Oligonucleotides Consumption Value by Application (2018-2023) & (USD Million)
    Table 77. North America DNA & RNA Oligonucleotides Consumption Value by Application (2024-2029) & (USD Million)
    Table 78. North America DNA & RNA Oligonucleotides Consumption Value by Country (2018-2023) & (USD Million)
    Table 79. North America DNA & RNA Oligonucleotides Consumption Value by Country (2024-2029) & (USD Million)
    Table 80. Europe DNA & RNA Oligonucleotides Consumption Value by Type (2018-2023) & (USD Million)
    Table 81. Europe DNA & RNA Oligonucleotides Consumption Value by Type (2024-2029) & (USD Million)
    Table 82. Europe DNA & RNA Oligonucleotides Consumption Value by Application (2018-2023) & (USD Million)
    Table 83. Europe DNA & RNA Oligonucleotides Consumption Value by Application (2024-2029) & (USD Million)
    Table 84. Europe DNA & RNA Oligonucleotides Consumption Value by Country (2018-2023) & (USD Million)
    Table 85. Europe DNA & RNA Oligonucleotides Consumption Value by Country (2024-2029) & (USD Million)
    Table 86. Asia-Pacific DNA & RNA Oligonucleotides Consumption Value by Type (2018-2023) & (USD Million)
    Table 87. Asia-Pacific DNA & RNA Oligonucleotides Consumption Value by Type (2024-2029) & (USD Million)
    Table 88. Asia-Pacific DNA & RNA Oligonucleotides Consumption Value by Application (2018-2023) & (USD Million)
    Table 89. Asia-Pacific DNA & RNA Oligonucleotides Consumption Value by Application (2024-2029) & (USD Million)
    Table 90. Asia-Pacific DNA & RNA Oligonucleotides Consumption Value by Region (2018-2023) & (USD Million)
    Table 91. Asia-Pacific DNA & RNA Oligonucleotides Consumption Value by Region (2024-2029) & (USD Million)
    Table 92. South America DNA & RNA Oligonucleotides Consumption Value by Type (2018-2023) & (USD Million)
    Table 93. South America DNA & RNA Oligonucleotides Consumption Value by Type (2024-2029) & (USD Million)
    Table 94. South America DNA & RNA Oligonucleotides Consumption Value by Application (2018-2023) & (USD Million)
    Table 95. South America DNA & RNA Oligonucleotides Consumption Value by Application (2024-2029) & (USD Million)
    Table 96. South America DNA & RNA Oligonucleotides Consumption Value by Country (2018-2023) & (USD Million)
    Table 97. South America DNA & RNA Oligonucleotides Consumption Value by Country (2024-2029) & (USD Million)
    Table 98. Middle East & Africa DNA & RNA Oligonucleotides Consumption Value by Type (2018-2023) & (USD Million)
    Table 99. Middle East & Africa DNA & RNA Oligonucleotides Consumption Value by Type (2024-2029) & (USD Million)
    Table 100. Middle East & Africa DNA & RNA Oligonucleotides Consumption Value by Application (2018-2023) & (USD Million)
    Table 101. Middle East & Africa DNA & RNA Oligonucleotides Consumption Value by Application (2024-2029) & (USD Million)
    Table 102. Middle East & Africa DNA & RNA Oligonucleotides Consumption Value by Country (2018-2023) & (USD Million)
    Table 103. Middle East & Africa DNA & RNA Oligonucleotides Consumption Value by Country (2024-2029) & (USD Million)
    Table 104. DNA & RNA Oligonucleotides Raw Material
    Table 105. Key Suppliers of DNA & RNA Oligonucleotides Raw Materials
List of Figures
    Figure 1. DNA & RNA Oligonucleotides Picture
    Figure 2. Global DNA & RNA Oligonucleotides Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
    Figure 3. Global DNA & RNA Oligonucleotides Consumption Value Market Share by Type in 2022
    Figure 4. DNA Oligonucleotides
    Figure 5. RNA Oligonucleotides
    Figure 6. Global DNA & RNA Oligonucleotides Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
    Figure 7. DNA & RNA Oligonucleotides Consumption Value Market Share by Application in 2022
    Figure 8. Hospitals and Clinics Picture
    Figure 9. Biopharma Companies Picture
    Figure 10. Academic & Research Organizations Picture
    Figure 11. Others Picture
    Figure 12. Global DNA & RNA Oligonucleotides Consumption Value, (USD Million): 2018 & 2022 & 2029
    Figure 13. Global DNA & RNA Oligonucleotides Consumption Value and Forecast (2018-2029) & (USD Million)
    Figure 14. Global Market DNA & RNA Oligonucleotides Consumption Value (USD Million) Comparison by Region (2018 & 2022 & 2029)
    Figure 15. Global DNA & RNA Oligonucleotides Consumption Value Market Share by Region (2018-2029)
    Figure 16. Global DNA & RNA Oligonucleotides Consumption Value Market Share by Region in 2022
    Figure 17. North America DNA & RNA Oligonucleotides Consumption Value (2018-2029) & (USD Million)
    Figure 18. Europe DNA & RNA Oligonucleotides Consumption Value (2018-2029) & (USD Million)
    Figure 19. Asia-Pacific DNA & RNA Oligonucleotides Consumption Value (2018-2029) & (USD Million)
    Figure 20. South America DNA & RNA Oligonucleotides Consumption Value (2018-2029) & (USD Million)
    Figure 21. Middle East and Africa DNA & RNA Oligonucleotides Consumption Value (2018-2029) & (USD Million)
    Figure 22. Global DNA & RNA Oligonucleotides Revenue Share by Players in 2022
    Figure 23. DNA & RNA Oligonucleotides Market Share by Company Type (Tier 1, Tier 2 and Tier 3) in 2022
    Figure 24. Global Top 3 Players DNA & RNA Oligonucleotides Market Share in 2022
    Figure 25. Global Top 6 Players DNA & RNA Oligonucleotides Market Share in 2022
    Figure 26. Global DNA & RNA Oligonucleotides Consumption Value Share by Type (2018-2023)
    Figure 27. Global DNA & RNA Oligonucleotides Market Share Forecast by Type (2024-2029)
    Figure 28. Global DNA & RNA Oligonucleotides Consumption Value Share by Application (2018-2023)
    Figure 29. Global DNA & RNA Oligonucleotides Market Share Forecast by Application (2024-2029)
    Figure 30. North America DNA & RNA Oligonucleotides Consumption Value Market Share by Type (2018-2029)
    Figure 31. North America DNA & RNA Oligonucleotides Consumption Value Market Share by Application (2018-2029)
    Figure 32. North America DNA & RNA Oligonucleotides Consumption Value Market Share by Country (2018-2029)
    Figure 33. United States DNA & RNA Oligonucleotides Consumption Value (2018-2029) & (USD Million)
    Figure 34. Canada DNA & RNA Oligonucleotides Consumption Value (2018-2029) & (USD Million)
    Figure 35. Mexico DNA & RNA Oligonucleotides Consumption Value (2018-2029) & (USD Million)
    Figure 36. Europe DNA & RNA Oligonucleotides Consumption Value Market Share by Type (2018-2029)
    Figure 37. Europe DNA & RNA Oligonucleotides Consumption Value Market Share by Application (2018-2029)
    Figure 38. Europe DNA & RNA Oligonucleotides Consumption Value Market Share by Country (2018-2029)
    Figure 39. Germany DNA & RNA Oligonucleotides Consumption Value (2018-2029) & (USD Million)
    Figure 40. France DNA & RNA Oligonucleotides Consumption Value (2018-2029) & (USD Million)
    Figure 41. United Kingdom DNA & RNA Oligonucleotides Consumption Value (2018-2029) & (USD Million)
    Figure 42. Russia DNA & RNA Oligonucleotides Consumption Value (2018-2029) & (USD Million)
    Figure 43. Italy DNA & RNA Oligonucleotides Consumption Value (2018-2029) & (USD Million)
    Figure 44. Asia-Pacific DNA & RNA Oligonucleotides Consumption Value Market Share by Type (2018-2029)
    Figure 45. Asia-Pacific DNA & RNA Oligonucleotides Consumption Value Market Share by Application (2018-2029)
    Figure 46. Asia-Pacific DNA & RNA Oligonucleotides Consumption Value Market Share by Region (2018-2029)
    Figure 47. China DNA & RNA Oligonucleotides Consumption Value (2018-2029) & (USD Million)
    Figure 48. Japan DNA & RNA Oligonucleotides Consumption Value (2018-2029) & (USD Million)
    Figure 49. South Korea DNA & RNA Oligonucleotides Consumption Value (2018-2029) & (USD Million)
    Figure 50. India DNA & RNA Oligonucleotides Consumption Value (2018-2029) & (USD Million)
    Figure 51. Southeast Asia DNA & RNA Oligonucleotides Consumption Value (2018-2029) & (USD Million)
    Figure 52. Australia DNA & RNA Oligonucleotides Consumption Value (2018-2029) & (USD Million)
    Figure 53. South America DNA & RNA Oligonucleotides Consumption Value Market Share by Type (2018-2029)
    Figure 54. South America DNA & RNA Oligonucleotides Consumption Value Market Share by Application (2018-2029)
    Figure 55. South America DNA & RNA Oligonucleotides Consumption Value Market Share by Country (2018-2029)
    Figure 56. Brazil DNA & RNA Oligonucleotides Consumption Value (2018-2029) & (USD Million)
    Figure 57. Argentina DNA & RNA Oligonucleotides Consumption Value (2018-2029) & (USD Million)
    Figure 58. Middle East and Africa DNA & RNA Oligonucleotides Consumption Value Market Share by Type (2018-2029)
    Figure 59. Middle East and Africa DNA & RNA Oligonucleotides Consumption Value Market Share by Application (2018-2029)
    Figure 60. Middle East and Africa DNA & RNA Oligonucleotides Consumption Value Market Share by Country (2018-2029)
    Figure 61. Turkey DNA & RNA Oligonucleotides Consumption Value (2018-2029) & (USD Million)
    Figure 62. Saudi Arabia DNA & RNA Oligonucleotides Consumption Value (2018-2029) & (USD Million)
    Figure 63. UAE DNA & RNA Oligonucleotides Consumption Value (2018-2029) & (USD Million)
    Figure 64. DNA & RNA Oligonucleotides Market Drivers
    Figure 65. DNA & RNA Oligonucleotides Market Restraints
    Figure 66. DNA & RNA Oligonucleotides Market Trends
    Figure 67. Porters Five Forces Analysis
    Figure 68. Manufacturing Cost Structure Analysis of DNA & RNA Oligonucleotides in 2022
    Figure 69. Manufacturing Process Analysis of DNA & RNA Oligonucleotides
    Figure 70. DNA & RNA Oligonucleotides Industrial Chain
    Figure 71. Methodology
    Figure 72. Research Process and Data Source

Research Methodology

Client Requirements

Review and analyze client requirements

Discussion of all the project requirements and queries

Flexibility Check

Project Feasibility Analysis

Finalizing tentative research programme

Structuring project proposal with scope, timeline, and costs

Analyzing Market Dynamics

Determination of key drivers, restraints, challenge, and opportunity

Identifies market needs and trends

Market Size Estimation & Forecast

Estimation of historical data based on secondary and primary data

Anticipating market recast by assigning weightage to market forces (drivers, restraints, opportunities)

Freezing historical and forecast market size estimations based on evolution, trends, outlook, and strategies

Consideration of geography, region-specific product/service demand for region segments

Consideration of product utilization rates, product demand outlook for segments by application or end-user.

Data Source

Secondary Source
Data collections from annual reports, presentations,associations, journals, analyst reports, paid database, press releases, blogs, newsletters,and GIR repositories.

Primary Source
Research discussion with manufacturers, distributors, suppliers, end user, industry experts to verify insights.

Validation and
triangulation of
secondary and primary source.

Collection of data

Cumulating and collating the essential qualitative and quantitative data

Generation of report in client requested format by research analysts

Reviews by expert analysts

Final quality check

Clarifying queries

Receiving feedback

Ensuring satisfaction

01 Identification of data

This step involves identification of several primary and secondary data research sources, including Global Info Research's internal data sources. The primary sources consist of in-depth discussions and interviews with policy makers, industry experts, and data evaluators, whereas secondary sources include a thorough study of market journals, press releases, annual reports, and government and non-government agencies websites.
02 Evaluation of Market Dynamic

This phase includes a detailed evaluation of several factors that are likely to affect the market dynamics. It involves a comprehensive assessment of major market pain points, drivers, and trends. It also comprises a detailed study of research plans and methodology.
03 Collection of Data

This process consists of gathering data, accessing proprietary databases, and reaching out to key industry participants that operate in the market across the value chain. It also involves studying several patterns in the historical data and comparing it with the current scenario.
04 Collaboration of Data

This stage involves the validation of data and arrival at actual statistics, and evolution of the market over the years. It entails the study and analyzes various segments and verticals of the market. An impact analysis is also performed to observe which factors will affect the market in the next few years.
05 Verification and Analysis

This is the final stage, which involves both quantity and quality checks. Although the process of data verification is an integral part of the research process, all data points and statistics and figures are re-checked to uphold their authenticity and validity.

Companies Mentioned

Eurofins Scientific
Natera
BGI
Illumina
Roche
LabCorp
Berry Genomics
Brooks Life Sciences
Macrogen
Genotypic Technology
Dna Link

Related Reports

Global DNA & RNA Oligonucleotides Market 2024 by Company, Regions, Type and Application, Forecast to 2030

Global DNA & RNA Oligonucleotides Market 2024 by Company, Regions, Type and Application, Forecast to 2030

date 02 Jan 2024

date Pharma & Healthcare

According to our (Global Info Research) latest study, the global DNA & RNA Oligonucleotides market size was valued at USD 1290.3 million in 2023 and is forecast to a readjusted size of USD 1512.6 million by 2030 with a CAGR of 2.3% during review period.

Product Tags

DNA & RNA Oligonucleotides

GABA Supplements

L-carnitine Capsule

Opical Thrombin

Purchase Options

Single User License

USD3480.00

Multi User License

USD5220.00

Corporate Users License

USD6960.00

Add To Cart

Buy Now

Popular Product Keywords

AI
semiconductor
electron
5G
artificial intelligence
Battery
new energy
We Provide Professional, Accurate Market Analysis to Help You Stay Ahead of Your Competition.

Speak to our analyst >>
Our Clients
What We Can Provide?

With better results and higher quality products,Our professional reports can achieve four things:
- Insight into the industry market information
- Analyze market development needs
- Prospects for future development
- Develop industry investment strategy
Digging deeper into global industry information and providing market strategies.

Contact Us >>